Eterna Therapeutics
ERNA
#10054
Rank
โ‚น1.14 B
Marketcap
โ‚น22.33
Share price
0.75%
Change (1 day)
-87.96%
Change (1 year)

Operating Margin for Eterna Therapeutics (ERNA)

Operating Margin as of March 2025 (TTM): -6,876.75%

According to Eterna Therapeutics's latest financial reports and stock price the company's current Operating Margin is -6,876.75%. At the end of 2023 the company had an Operating Margin of -31,869.12%.

Operating Margin history for Eterna Therapeutics from 2024 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-31,869.12%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
1.11%-100.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-226.73%-96.70%๐Ÿ‡บ๐Ÿ‡ธ USA
-467.67%-93.20%๐Ÿ‡บ๐Ÿ‡ธ USA
15.12%-100.22%๐Ÿ‡ซ๐Ÿ‡ท France
16.02%-100.23%๐Ÿ‡บ๐Ÿ‡ธ USA
-156.78%-97.72%๐Ÿ‡ฆ๐Ÿ‡บ Australia
-7.76%-99.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.